STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
15
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $0 priced
What the filings say about ZEPP
Insiders, 180 days
-$87.5K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$86.6K
1 notice
Zepp Health insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Zepp Health Corp insiders sold a net $87.5K of stock across 3 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 8.6% of the 114,539 shares held after it.
No other insider sold within 30 days.
15 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Deng Cheng sold about $45.3K of ZEPP on Jun 26, 2026, the largest insider sale at the company on our record; 15 funds added in the latest 13F quarter.
3 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ZEPP planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Yu Pengtao
Filed 2026-09-23
$86.6K
Deng Cheng
Filed 2026-06-26
$47.6K
ZEPP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Global X Internet of Things ETF
$248.1K position · as of 2026-05-31
0.1%
T. Rowe Price International Discovery Fund
$1.1M position · as of 2026-07-31
0.0%
Allspring Emerging Markets Equity Fund
$211.8K position · as of 2026-07-31
0.0%
T. Rowe Price Global Allocation Fund
$4.0K position · as of 2026-07-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $87.5K sold by insiders over 180 days, 15 funds added last quarter, $86.6K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
fewer than four consecutive quarters of net income
Return on equity ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing ZEPP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ZEPP ranks highest on growth (88th percentile) and risk and compliance (48th), and lowest on institutional and government (19th), among Tech Hardware peers.
Financial health
41
Inputs
Debt to equity0.28x · 41 pct, sector of 72
Cash flow to debtneeds four quarters of operating cash flow
Growth
88
Inputs
Revenue growth, YoY+41.8% · 88 pct, sector of 102
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
38
Inputs
Net Form 4 buying (codes P and S), 180d-$87K · 76 pct, sector of 75
Insider buyers, 180d0 · 0 pct, sector of 77
Institutional and government
19
Inputs
Funds adding, latest quarter15 · 19 pct, sector of 89
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
48
Inputs
Short interest, % of float+5.3% · 48 pct, sector of 105
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Profitability, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ZEPP filings, in plain words
Are Zepp Health insiders buying or selling ZEPP?
In the 180 days to 2026-10-28, Zepp Health insiders were net sellers, a net $87.5K across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of ZEPP?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $86.6K of stock; the latest, by Yu Pengtao, was filed 2026-09-23.
Read the full summary
In the 180 days to 2026-10-28, Zepp Health insiders were net sellers of ZEPP, a net $87.5K across purchases and sales reported on Form 4 by 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $86.6K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.